The principal aim of the course is to provide a comprehensive and detailed understanding of the decision-making process for the management of all types and stages of skin cancer. This will include diagnosis and primary treatment, management of locoregional disease and distant metastatic disease, and adjuvant treatment. This is particularly relevant given the rapid progress in our understanding of melanoma and non-melanoma skin cancer, and the development of new treatments. In particular delegates will acquire the following knowledge:

  1. Strategies for diagnosis of melanoma, Merkel cell and non-melanoma skin cancer including dermoscopy and confocal laser microscopy.
  2. The indications, risks and benefits and strategies for mole screening.
  3. Diagnosis of skin cancer: how to break bad news.
  4. The indications and methods for genetic diagnosis and genetic counseling of skin cancer patients.
  5. The present AJCC staging systems and how to stage melanoma, Merkel cell and cutaneous squamous cell carcinoma, and other non-melanoma skin cancers.
  6. The value of imaging and biomarkers for the detection of metastases and disease staging.
  7. Adjuvant treatment of skin cancer: radiotherapy, immunotherapy, chemotherapy.
  8. New systemic treatments for stage IV melanoma: targeted agents and immunotherapeutics.
  9. New treatment options of advanced basal cell carcinoma.
  10. New systemic treatments for advanced Merkel cell and squamous cell carcinoma.
  11. The characteristics of mucosal and uveal melanomas and their treatment options.
  12. Options for topical treatment of epithelial skin cancers.
  13. The current classification of cutaneous lymphoma, staging and treatment options for different subtypes of cutaneous lymphoma.
  14. Clinical trials in skin cancer: an update.
  15. The indications and strategies for supportive treatments including best supportive care.